Nuclear medicine
Nuclyscan®
Next-generation total-body PET/CT scanner
Nuclyscan introduces a new detector technology designed to overcome traditional PET imaging trade-offs, combining high sensitivity, state-of-the-art spatial resolution and a cost-efficient system architecture.
More precision. More insight. Less cost.
Designed for total-body quantitative imaging, Nuclyscan enables comprehensive assessment of biological processes across the entire body, supporting oncology, neurology, cardiovascular imaging, clinical trials and pharmacokinetic studies.
See the whole picture.
From detection to decision.
Whole-body quantitative imaging for clinical and research applications.
- Enable real-time, whole-body tracking of metabolic activity
- Reveal how biological processes evolve dynamically across organs rather than as isolated snapshots
- Support more precise, personalized therapeutic decision making
Proven imaging performance
- High-quality brain imaging demon-strated on prototype
- Reconstructed spatial resolution down to 2.6 mm (NEMA NU 2 testing of prototype)
- Market-leading spatial resolution as evidenced by the Jaszczak phantom measurement with clear visualization of small rods
- Depth of Interaction sensitivity for reduced parallax error
Brain PET imaging
Nuclyscan Spatial Resolution (NEMA NU 2), compared to leading TB-PET vendors.
Jaszczak phantom
Unlock the full potential of nuclear imaging
Beyond routine diagnostics, Nuclyscan supports therapy and drug development by helping clinicians and researchers see what they treat and treat what they see.